Chenzhou Dijia Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chenzhou Dijia Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include WHBAYSYH. The owner is based in Chenzhou City, Hunan Province.

Room 1833, Dahua Tiandu, No. 968, Nanling Avenue, Luoxian Street, Beihu District

Chenzhou City, Hunan Province 423000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WHBAYSYH
WHBAYSYH
Registered 2025

Trademark Classifications

Chenzhou Dijia Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Chenzhou Dijia Biotechnology Co., Ltd. have?

Chenzhou Dijia Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chenzhou Dijia Biotechnology Co., Ltd. file in?

Chenzhou Dijia Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Chenzhou Dijia Biotechnology Co., Ltd.'s most well-known trademarks?

Chenzhou Dijia Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as WHBAYSYH. These are among 1 currently registered trademark in the portfolio.

What is Chenzhou Dijia Biotechnology Co., Ltd.'s trademark registration success rate?

Chenzhou Dijia Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.